These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 9128388)
41. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship. Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306 [TBL] [Abstract][Full Text] [Related]
43. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934 [TBL] [Abstract][Full Text] [Related]
44. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis. Dididze MN Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218 [TBL] [Abstract][Full Text] [Related]
45. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Koga M; Takahashi M; Masuda M; Hirata K; Yuki N Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859 [TBL] [Abstract][Full Text] [Related]
46. Rehabilitation outcomes after combined acute disseminated encephalomyelitis and Guillain-Barré syndrome in a child: a case report. Korupolu R; Ngo T; Hack N; Escott E; Salles S J Pediatr Rehabil Med; 2014; 7(3):267-72. PubMed ID: 25260509 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study. Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814 [TBL] [Abstract][Full Text] [Related]
49. Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome? Jung S; Zimmer S; Lüneberg E; Frosch M; Karch H; Korn T; Toyka KV Neurosci Lett; 2005 Jun 10-17; 381(1-2):175-8. PubMed ID: 15882812 [TBL] [Abstract][Full Text] [Related]
50. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419 [TBL] [Abstract][Full Text] [Related]
52. [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis]. Hartung HP; Heininger K; Toyka KV Nervenarzt; 1990 Apr; 61(4):197-207. PubMed ID: 2191228 [TBL] [Abstract][Full Text] [Related]
53. The causes of the syndromes of Landry (1859) and of Guillain, Barré and Strohl (1916). Alvord EC; Jahnke U; Fischer EH Rev Neurol (Paris); 1987; 143(8-9):571-9. PubMed ID: 2445014 [TBL] [Abstract][Full Text] [Related]
54. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis. Nicoletti F; Créange A; Orlikowski D; Bolgert F; Mangano K; Metz C; Di Marco R; Al Abed Y J Neuroimmunol; 2005 Nov; 168(1-2):168-74. PubMed ID: 16171874 [TBL] [Abstract][Full Text] [Related]
55. [Clinical symptoms and diagnostic criteria in polyradiculitis--Landry Guillain Barré]. Grisold W; Drlicek M; Liszka U Wien Klin Wochenschr Suppl; 1991; 190():3-7. PubMed ID: 1771903 [TBL] [Abstract][Full Text] [Related]
56. Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barré syndrome associated with H1N1 09 influenza vaccination. Hoshino T; Uchiyama Y; Ito E; Osawa S; Ohashi T Intern Med; 2012; 51(12):1595-8. PubMed ID: 22728497 [TBL] [Abstract][Full Text] [Related]
57. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome. Koski CL; Gratz E; Sutherland J; Mayer RF Ann Neurol; 1986 Jun; 19(6):573-7. PubMed ID: 3729311 [TBL] [Abstract][Full Text] [Related]
58. The landry-guillain-barré strohl syndrome 1859 to 1992 a historical perspective. Afifi AK J Family Community Med; 1994 Jan; 1(1):30-4. PubMed ID: 23008532 [TBL] [Abstract][Full Text] [Related]
59. Demyelination in vivo by Guillain-Barré syndrome and other human serum. Brown MJ; Rosen JL; Lisak RP Muscle Nerve; 1987; 10(3):263-71. PubMed ID: 3561445 [TBL] [Abstract][Full Text] [Related]